433 related articles for article (PubMed ID: 27460691)
1. Effect of endoscopic pyloric therapies for patients with nausea and vomiting and functional obstructive gastroparesis.
Wellington J; Scott B; Kundu S; Stuart P; Koch KL
Auton Neurosci; 2017 Jan; 202():56-61. PubMed ID: 27460691
[TBL] [Abstract][Full Text] [Related]
2. Gastric myoelectrical activity based AI-derived threshold predicts resolution of gastroparesis post-pyloric balloon dilation.
Noar M; Khan S
Surg Endosc; 2023 Mar; 37(3):1789-1798. PubMed ID: 36229558
[TBL] [Abstract][Full Text] [Related]
3. Pyloric injection of botulinum toxin for treatment of diabetic gastroparesis.
Ezzeddine D; Jit R; Katz N; Gopalswamy N; Bhutani MS
Gastrointest Endosc; 2002 Jun; 55(7):920-3. PubMed ID: 12024156
[TBL] [Abstract][Full Text] [Related]
4. Obstructive Gastroparesis: Patient Selection and Effect of Laparoscopic Pyloroplasty.
Wellington J; Stuart P; Westcott C; Koch KL
J Gastrointest Surg; 2020 Aug; 24(8):1778-1784. PubMed ID: 31270719
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the pylorus with concurrent intraluminal pressure and EndoFLIP in patients with nausea and vomiting.
Snape WJ; Lin MS; Agarwal N; Shaw RE
Neurogastroenterol Motil; 2016 May; 28(5):758-64. PubMed ID: 26813266
[TBL] [Abstract][Full Text] [Related]
6. Gastric myoelectrical activity in patients with gastric outlet obstruction and idiopathic gastroparesis.
Brzana RJ; Koch KL; Bingaman S
Am J Gastroenterol; 1998 Oct; 93(10):1803-9. PubMed ID: 9772035
[TBL] [Abstract][Full Text] [Related]
7. The treatment of diabetic gastroparesis with botulinum toxin injection of the pylorus.
Lacy BE; Crowell MD; Schettler-Duncan A; Mathis C; Pasricha PJ
Diabetes Care; 2004 Oct; 27(10):2341-7. PubMed ID: 15451898
[TBL] [Abstract][Full Text] [Related]
8. Gastric electrical stimulation: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(16):1-79. PubMed ID: 23074486
[TBL] [Abstract][Full Text] [Related]
9. Endoscopic pyloric injection of botulinum toxin A for the treatment of refractory gastroparesis.
Bromer MQ; Friedenberg F; Miller LS; Fisher RS; Swartz K; Parkman HP
Gastrointest Endosc; 2005 Jun; 61(7):833-9. PubMed ID: 15933684
[TBL] [Abstract][Full Text] [Related]
10. Low Vitamin D Levels in Patients with Symptoms of Gastroparesis: Relationships with Nausea and Vomiting, Gastric Emptying and Gastric Myoelectrical Activity.
Koch KL; Parkman HP; Yates KP; Van Natta ML; Grover M; Farrugia G; Abell TL; McCallum RW; Sarosiek I; Kuo B; Shulman RJ; Miriel L; Tonascia J; Pasricha PJ
Dig Dis Sci; 2024 Jun; ():. PubMed ID: 38877334
[TBL] [Abstract][Full Text] [Related]
11. Pyloric sphincter characteristics using EndoFLIP
Saadi M; Yu D; Malik Z; Parkman HP; Schey R
Rev Gastroenterol Mex (Engl Ed); 2018; 83(4):375-384. PubMed ID: 29709494
[TBL] [Abstract][Full Text] [Related]
12. Pyloric sphincter therapy: botulinum toxin, stents, and pyloromyotomy.
Clarke JO; Snape WJ
Gastroenterol Clin North Am; 2015 Mar; 44(1):127-36. PubMed ID: 25667028
[TBL] [Abstract][Full Text] [Related]
13. Endoscopic pyloric injection of botulinum toxin-A for the treatment of postvagotomy gastroparesis.
Reddymasu SC; Singh S; Sankula R; Lavenbarg TA; Olyaee M; McCallum RW
Am J Med Sci; 2009 Mar; 337(3):161-4. PubMed ID: 19174691
[TBL] [Abstract][Full Text] [Related]
14. Treatment of idiopathic gastroparesis with injection of botulinum toxin into the pyloric sphincter muscle.
Miller LS; Szych GA; Kantor SB; Bromer MQ; Knight LC; Maurer AH; Fisher RS; Parkman HP
Am J Gastroenterol; 2002 Jul; 97(7):1653-60. PubMed ID: 12135014
[TBL] [Abstract][Full Text] [Related]
15. [Gastroparesis--diagnosis and treatment].
Ciortescu I; Stanciu C
Rev Med Chir Soc Med Nat Iasi; 2009; 113(2):330-8. PubMed ID: 21495337
[TBL] [Abstract][Full Text] [Related]
16. Effect of liquid and solid test meals on symptoms and gastric myoelectrical activity in patients with gastroparesis and functional dyspepsia.
Koch KL; Van Natta M; Parkman HP; Grover M; Abell TL; McCallum RW; Shaltout HA; Sarosiek I; Farrugia G; Shulman RJ; Tonascia J; Miriel L; Hamilton F; Pasricha PJ;
Neurogastroenterol Motil; 2023 Feb; 35(2):e14376. PubMed ID: 35411675
[TBL] [Abstract][Full Text] [Related]
17. Endoscopic intrapyloric injection of botulinum toxin A in the treatment of children with gastroparesis: a retrospective, open-label study.
Rodriguez L; Rosen R; Manfredi M; Nurko S
Gastrointest Endosc; 2012 Feb; 75(2):302-9. PubMed ID: 22248598
[TBL] [Abstract][Full Text] [Related]
18. Endoscopic and Surgical Treatments for Gastroparesis: What to Do and Whom to Treat?
Petrov RV; Bakhos CT; Abbas AE; Malik Z; Parkman HP
Gastroenterol Clin North Am; 2020 Sep; 49(3):539-556. PubMed ID: 32718569
[TBL] [Abstract][Full Text] [Related]
19. Satiety testing in diabetic gastroparesis: Effects of insulin pump therapy with continuous glucose monitoring on upper gastrointestinal symptoms and gastric myoelectrical activity.
Koch KL; Hasler WL; Van Natta M; Calles-Escandon J; Grover M; Pasricha PJ; Snape WJ; Parkman HP; Abell TL; McCallum RW; Nguyen LA; Sarosiek I; Farrugia G; Tonascia J; Lee L; Miriel L; Hamilton F;
Neurogastroenterol Motil; 2020 Jan; 32(1):e13720. PubMed ID: 31574209
[TBL] [Abstract][Full Text] [Related]
20. Pyloric distensibility measurement predicts symptomatic response to intrapyloric botulinum toxin injection.
Desprez C; Melchior C; Wuestenberghs F; Zalar A; Jacques J; Leroi AM; Gourcerol G
Gastrointest Endosc; 2019 Nov; 90(5):754-760.e1. PubMed ID: 31028783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
